Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Cancer

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1223442

Cover Image

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1223442

Global Colorectal Cancer Diagnostics Market - Industry Trends and Forecast to 2030

PUBLISHED:
PAGES: 402 Pages
DELIVERY TIME: Inquiry
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License) - Printable/Downloadable
USD 4800
PDF (Enterprise License) - Printable/Downloadable
USD 7000

Add to Cart

Description

Table of Contents

List of Tables

Global colorectal cancer diagnostics market is projected to register a substantial CAGR of 8.4% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation:

Global Colorectal Cancer Diagnostics Market, By Product Type (Instruments and Consumables & Accessories), Test Type (Stool Examination, Blood Test, Imaging Test, Tumor Markers, Biopsy, and Others), Stages (Stage 0, Stage I, Stage II, Stage III, and Stage IV), Cancer Type (Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors, and Others), Age Group (Geriatric, Adults, and Pediatric), End User (Hospital, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgical Centers, Academic Institutes, and Others), Country (U.S., Canada, Mexico, Germany, France, U.K, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium, Ireland, Poland, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, and Rest of Middle East and Africa) Industry Trends and Forecast to 2030.

Some of the factors that can affect the growth of the market are:

Growing prevalence of colorectal cancer

Increasing healthcare expenditure on cancer diagnosis and treatment in colorectal cancer diagnostics

Market Players:

The key market players in global colorectal cancer diagnostics market are listed below:

F. Hoffmann-La Roche Ltd.

Abbott.

Illumina

QIAGEN

Thermo Fisher Scientific Inc.

Quest Diagnostics Incorporated, Inc.

Merck KGaA.

Hologic, Inc.

General Electric Company

Siemens Healthcare GmbH

BD

Myriad Genetics, Inc.

Koninklijke Philips N.V.

Beijing O&D Biotech Co., Ltd

PlexBio Co, Ltd.

FUJIFILM Corporation

CANON MEDICAL SYSTEMS CORPORATION

FONAR Corp.

Medonica Co. LTD

MinFound Medical Systems Co

Sternmed GmbH

Time Medical Holding.

Bio-Rad Laboratories, Inc.

Neusoft Corporation

BioFire Diagnostics

Agilent Technologies, Inc.

GE HealthCare.

Show more

TABLE OF CONTENTS

1 INTRODUCTION 44

  • 1.1 OBJECTIVES OF THE STUDY 44
  • 1.2 MARKET DEFINITION 44
  • 1.3 OVERVIEW OF THE GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET 44
  • 1.4 LIMITATIONS 46
  • 1.5 MARKETS COVERED 46

2 MARKET SEGMENTATION 49

  • 2.1 MARKETS COVERED 49
  • 2.2 GEOGRAPHICAL SCOPE 50
  • 2.3 YEARS CONSIDERED FOR THE STUDY 51
  • 2.4 CURRENCY AND PRICING 51
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 52
  • 2.6 MULTIVARIATE MODELLING 55
  • 2.7 PRODUCT TYPE LIFELINE CURVE 55
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 56
  • 2.9 DBMR MARKET POSITION GRID 57
  • 2.10 MARKET END USER COVERAGE GRID 58
  • 2.11 VENDOR SHARE ANALYSIS 59
  • 2.12 SECONDARY SOURCES 60
  • 2.13 ASSUMPTIONS 60

3 EXECUTIVE SUMMARY 61

4 PREMIUM INSIGHTS 64

  • 4.1 PORTER'S FIVE FORCES 67
  • 4.2 PESTEL ANALYSIS 68

5 INDUSTRY INSIGHTS: 69

6 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET, REGULATIONS 70

  • 6.1 REGULATORY SCENARIO IN THE U.S 70
  • 6.2 REGULATORY SCENARIO IN AUSTRALIA 70
  • 6.3 REGULATORY SCENARIO IN JAPAN 71
  • 6.4 REGULATORY SCENARIO IN CHINA 71

7 MARKET OVERVIEW 73

  • 7.1 DRIVERS 75
    • 7.1.1 GROWING PREVALENCE OF COLORECTAL CANCER 75
    • 7.1.2 RISE IN THE NUMBER OF PATIENTS SUFFERING FROM DIVERTICULITIS AND ULCERATIVE COLITIS. 75
    • 7.1.3 RISING PREFERENCE FOR PREVENTIVE HEALTH CHECK-UPS 75
  • 7.2 RESTRAINTS 76
    • 7.2.1 STRINGENT REGULATORY POLICIES 76
    • 7.2.2 HIGH COST FOR THE COLORECTAL CANCER TREATMENTS. 76
  • 7.3 OPPORTUNITIES 77
    • 7.3.1 RISE IN HEALTHCARE EXPENDITURE FOR CANCER DIAGNOSIS AND TREATMENT 77
    • 7.3.2 GOVERNMENT INITIATIVES TOWARD CANCER DIAGNOSTICS 78
    • 7.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 78
  • 7.4 CHALLENGES 79
    • 7.4.1 INCREASED COST, SAFETY, AND CONVENIENCE ISSUES 79
    • 7.4.2 LACK OF SKILLED AND CERTIFIED PROFESSIONALS 80

8 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE 81

  • 8.1 OVERVIEW 82
  • 8.2 INSTRUMENTS 85
    • 8.2.1 PATHOLOGY-BASED INSTRUMENTS 86
      • 8.2.1.1 PCR INSTRUMENTS 86
      • 8.2.1.2 SLIDE STAINING SYSTEMS 86
      • 8.2.1.3 TISSUE PROCESSING SYSTEMS 87
      • 8.2.1.4 CELL PROCESSORS 87
      • 8.2.1.5 OTHER PATHOLOGY-BASED INSTRUMENTS 87
    • 8.2.2 IMAGING INSTRUMENTS 87
      • 8.2.2.1 ULTRASOUND SYSTEMS 87
      • 8.2.2.2 CT SYSTEMS 87
      • 8.2.2.3 MRI SYSTEMS 88
      • 8.2.2.4 OTHERS 88
    • 8.2.3 BIOPSY INSTRUMENTS 88
    • 8.2.4 OTHERS 88
  • 8.3 CONSUMABLES & ACCESSORIES 88
    • 8.3.1 KITS 89
      • 8.3.1.1 PCR KITS 89
      • 8.3.1.2 DNA POLYMERASE KITS 89
      • 8.3.1.3 NUCLEIC ACID ISOLATION KITS 89
      • 8.3.1.4 OTHERS 90
    • 8.3.2 REAGENTS 90
      • 8.3.2.1 ASSAYS 90
      • 8.3.2.2 BUFFERS 90
      • 8.3.2.3 PRIMERS 90
      • 8.3.2.4 OTHERS 90
    • 8.3.3 OTHER CONSUMABLES 90

9 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE 91

  • 9.1 OVERVIEW 92
  • 9.2 STOOL EXAMINATION 95
  • 9.3 BLOOD TEST 95
    • 9.3.1 COMPLETE BLOOD COUNT (CBC) 96
    • 9.3.2 TUMOR MARKER TEST 97
    • 9.3.3 LIVER ENZYME BLOOD TEST 97
  • 9.4 IMAGING TEST 97
    • 9.4.1 COMPUTED TOMOGRAPHY (CT) SCAN 98
    • 9.4.2 MRI 98
    • 9.4.3 ULTRASOUND 98
    • 9.4.4 POSITION EMISSION TOMOGRAPHY (PET) 99
    • 9.4.5 OTHERS 99
  • 9.5 TUMOR MARKERS 99
    • 9.5.1 CARCINOEMBRYONIC ANTIGEN (CEA) 100
    • 9.5.2 CA19-9 BIOMARKER TEST 100
    • 9.5.3 CA 50 MARKER TEST 100
    • 9.5.4 OTHERS 100
  • 9.6 BIOPSY 100
  • 9.7 OTHERS 101

10 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES 102

  • 10.1 OVERVIEW 103
  • 10.2 STAGE III 106
  • 10.3 STAGE IV 106
  • 10.4 STAGE II 107
  • 10.5 STAGE I 108
  • 10.6 STAGE 0 108

11 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP 110

  • 11.1 OVERVIEW 111
  • 11.2 GERIATRIC 114
  • 11.3 ADULTS 114
  • 11.4 PEDIATRIC 115

12 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE 117

  • 12.1 OVERVIEW 118
  • 12.2 ADENOCARCINOMA 121
  • 12.3 COLORECTAL LYMPHOMA 121
  • 12.4 GASTROINTESTINAL STROMAL TUMORS 122
  • 12.5 CARCINOID TUMORS 123
  • 12.6 OTHERS 123

13 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER 125

  • 13.1 OVERVIEW 126
  • 13.2 HOSPITALS 129
  • 13.3 DIAGNOSTIC CENTERS 129
  • 13.4 CANCER RESEARCH CENTERS 130
  • 13.5 AMBULATORY SURGICAL CENTERS 131
  • 13.6 ACADEMIC INSTITUTES 131
  • 13.7 OTHERS 132

14 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION 134

  • 14.1 OVERVIEW 135
  • 14.2 NORTH AMERICA 140
    • 14.2.1 U.S. 149
    • 14.2.2 CANADA 154
    • 14.2.3 MEXICO 159
  • 14.3 EUROPE 164
    • 14.3.1 GERMANY 174
    • 14.3.2 FRANCE 179
    • 14.3.3 U.K. 184
    • 14.3.4 ITALY 189
    • 14.3.5 SPAIN 194
    • 14.3.6 RUSSIA 199
    • 14.3.7 TURKEY 204
    • 14.3.8 NETHERLANDS 209
    • 14.3.9 BELGIUM 214
    • 14.3.10 SWITZERLAND 219
    • 14.3.11 REST OF EUROPE 224
  • 14.4 ASIA-PACIFIC 225
    • 14.4.1 CHINA 235
    • 14.4.2 INDIA 240
    • 14.4.3 JAPAN 245
    • 14.4.4 SOUTH KOREA 250
    • 14.4.5 THAILAND 255
    • 14.4.6 SINGAPORE 260
    • 14.4.7 INDONESIA 265
    • 14.4.8 MALAYSIA 270
    • 14.4.9 PHILIPPINES 274
    • 14.4.10 AUSTRALIA 280
    • 14.4.11 VIETNAM 285
    • 14.4.12 REST OF ASIA-PACIFIC 290
  • 14.5 SOUTH AMERICA 291
    • 14.5.1 BRAZIL 300
    • 14.5.2 ARGENTINA 305
    • 14.5.3 REST OF SOUTH AMERICA 310
  • 14.6 MIDDLE EAST AND AFRICA 311
    • 14.6.1 SOUTH AFRICA 321
    • 14.6.2 SAUDI ARABIA 326
    • 14.6.3 U.A.E. 331
    • 14.6.4 EGYPT 336
    • 14.6.5 ISRAEL 341
    • 14.6.6 REST OF MIDDLE EAST AND AFRICA 346

15 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET, COMPANY LANDSCAPE 347

  • 15.1 COMPANY SHARE ANALYSIS: GLOBAL 347
  • 15.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 348
  • 15.3 COMPANY SHARE ANALYSIS: EUROPE 349
  • 15.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 350

16 SWOT ANALYSIS 351

17 COMPANY PROFILE 352

  • 17.1 F. HOFFMANN- LA ROCHE LTD 352
    • 17.1.1 COMPANY SNAPSHOT 352
    • 17.1.2 REVENUE ANALYSIS 352
    • 17.1.3 COMPANY SHARE ANALYSIS 353
    • 17.1.4 PRODUCT PORTFOLIO 353
    • 17.1.5 RECENT DEVELOPMENT 353
  • 17.2 KONINKLIJKE PHILIPS N.V. 354
    • 17.2.1 COMPANY SNAPSHOT 354
    • 17.2.2 REVENUE ANALYSIS 354
    • 17.2.3 COMPANY SHARE ANALYSIS 355
    • 17.2.4 PRODUCT PORTFOLIO 355
    • 17.2.5 RECENT DEVELOPMENT 355
  • 17.3 THERMO FISHER SCIENTIFIC INC. 357
    • 17.3.1 COMPANY SNAPSHOT 357
    • 17.3.2 REVENUE ANALYSIS 357
    • 17.3.3 COMPANY SHARE ANALYSIS 358
    • 17.3.4 PRODUCT PORTFOLIO 358
    • 17.3.5 RECENT DEVELOPMENT 358
  • 17.4 ILLUMINA, INC. 359
    • 17.4.1 COMPANY SNAPSHOT 359
    • 17.4.2 REVENUE ANALYSIS 359
    • 17.4.3 COMPANY SHARE ANALYSIS 360
    • 17.4.4 PRODUCT PORTFOLIO 360
    • 17.4.5 RECENT DEVELOPMENT 360
  • 17.5 QUEST DIAGNOSTICS INCORPORATED 361
    • 17.5.1 COMPANY SNAPSHOT 361
    • 17.5.2 REVENUE ANALYSIS 361
    • 17.5.3 COMPANY SHARE ANALYSIS 362
    • 17.5.4 PRODUCT PORTFOLIO 362
    • 17.5.5 RECENT DEVELOPMENT 362
  • 17.6 ABBOTT 363
    • 17.6.1 COMPANY SNAPSHOT 363
    • 17.6.2 REVENUE ANALYSIS 363
    • 17.6.3 PRODUCT PORTFOLIO 364
    • 17.6.4 RECENT DEVELOPMENT 364
  • 17.7 AGILENT TECHNOLOGIES, INC. 365
    • 17.7.1 COMPANY SNAPSHOT 365
    • 17.7.2 REVENUE ANALYSIS 365
    • 17.7.3 PRODUCT PORTFOLIO 366
    • 17.7.4 RECENT DEVELOPMENT 366
  • 17.8 BD 367
    • 17.8.1 COMPANY SNAPSHOT 367
    • 17.8.2 REVENUE ANALYSIS 367
    • 17.8.3 PRODUCT PORTFOLIO 368
    • 17.8.4 RECENT DEVELOPMENT 368
  • 17.9 BEIJING O&D BIOTECH CO., LTD. 369
    • 17.9.1 COMPANY SNAPSHOT 369
    • 17.9.2 PRODUCT PORTFOLIO 369
    • 17.9.3 RECENT DEVELOPMENT 369
  • 17.10 BIOFIRE DIAGNOSTICS 370
    • 17.10.1 COMPANY SNAPSHOT 370
    • 17.10.2 REVENUE ANALYSIS 370
    • 17.10.3 PRODUCT PORTFOLIO 371
    • 17.10.4 RECENT DEVELOPMENT 371
  • 17.11 BIO-RAD LABORATORIES, INC. 372
    • 17.11.1 COMPANY SNAPSHOT 372
    • 17.11.2 REVENUE ANALYSIS 372
    • 17.11.3 PRODUCT PORTFOLIO 373
    • 17.11.4 RECENT DEVELOPMENT 373
  • 17.12 CANON MEDICAL SYSTEMS CORPORATION. 374
    • 17.12.1 COMPANY SNAPSHOT 374
    • 17.12.2 REVENUE ANALYSIS 374
    • 17.12.3 PRODUCT PORTFOLIO 375
    • 17.12.4 RECENT DEVELOPMENT 375
  • 17.13 FONAR CORP. 376
    • 17.13.1 COMPANY SNAPSHOT 376
    • 17.13.2 REVENUE ANALYSIS 376
    • 17.13.3 PRODUCT PORTFOLIO 377
    • 17.13.4 RECENT DEVELOPMENT 377
  • 17.14 FUJIFILM CORPORATION 378
    • 17.14.1 COMPANY SNAPSHOT 378
    • 17.14.2 REVENUE ANALYSIS 378
    • 17.14.3 PRODUCT PORTFOLIO 379
    • 17.14.4 RECENT DEVELOPMENT 379
  • 17.15 GE HEALTHCARE. 380
    • 17.15.1 COMPANY SNAPSHOT 380
    • 17.15.2 REVENUE ANALYSIS 380
    • 17.15.3 PRODUCT PORTFOLIO 381
    • 17.15.4 RECENT DEVELOPMENT 381
  • 17.16 HOLOGIC, INC. 382
    • 17.16.1 COMPANY SNAPSHOT 382
    • 17.16.2 REVENUE ANALYSIS 382
    • 17.16.3 PRODUCT PORTFOLIO 383
    • 17.16.4 RECENT DEVELOPMENT 383
Show more
  • 17.17 MEDONICA CO. LTD 384
    • 17.17.1 COMPANY SNAPSHOT 384
    • 17.17.2 PRODUCT PORTFOLIO 384
    • 17.17.3 RECENT DEVELOPMENT 384
  • 17.18 MERCK KGAA 385
    • 17.18.1 COMPANY SNAPSHOT 385
    • 17.18.2 REVENUE ANALYSIS 385
    • 17.18.3 PRODUCT PORTFOLIO 386
    • 17.18.4 RECENT DEVELOPMENT 386
  • 17.19 MINFOUND MEDICAL SYSTEMS CO., LTD 387
    • 17.19.1 COMPANY SNAPSHOT 387
    • 17.19.2 PRODUCT PORTFOLIO 387
    • 17.19.3 RECENT DEVELOPMENT 387
  • 17.20 MYRIAD GENETICS, INC. 388
    • 17.20.1 COMPANY SNAPSHOT 388
    • 17.20.2 REVENUE ANALYSIS 388
    • 17.20.3 PRODUCT PORTFOLIO 389
    • 17.20.4 RECENT DEVELOPMENT 389
  • 17.21 NEUSOFT CORPORATION 390
    • 17.21.1 COMPANY SNAPSHOT 390
    • 17.21.2 REVENUE ANALYSIS 390
    • 17.21.3 PRODUCT PORTFOLIO 391
    • 17.21.4 RECENT DEVELOPMENT 391
  • 17.22 PLEXBIO 392
    • 17.22.1 COMPANY SNAPSHOT 392
    • 17.22.2 PRODUCT PORTFOLIO 392
    • 17.22.3 RECENT DEVELOPMENT 392
  • 17.23 QIAGEN 393
    • 17.23.1 COMPANY SNAPSHOT 393
    • 17.23.2 REVENUE ANALYSIS 393
    • 17.23.3 PRODUCT PORTFOLIO 394
    • 17.23.4 RECENT DEVELOPMENT 394
  • 17.24 SIEMENS HEALTHCARE GMBH 395
    • 17.24.1 COMPANY SNAPSHOT 395
    • 17.24.2 REVENUE ANALYSIS 395
    • 17.24.3 1.2.3 PRODUCT PORTFOLIO 396
    • 17.24.4 RECENT DEVELOPMENT 396
  • 17.25 STERNMED GMBH 397
    • 17.25.1 COMPANY SNAPSHOT 397
    • 17.25.2 PRODUCT PORTFOLIO 397
    • 17.25.3 RECENT DEVELOPMENT 397
  • 17.26 TIME MEDICAL HOLDING. 398
    • 17.26.1 COMPANY SNAPSHOT 398
    • 17.26.2 PRODUCT PORTFOLIO 398
    • 17.26.3 RECENT DEVELOPMENT 398

18 QUESTIONNAIRE 399

19 RELATED REPORTS 402

LIST OF TABLES

  • TABLE 1 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 84
  • TABLE 2 GLOBAL INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 85
  • TABLE 3 GLOBAL INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 86
  • TABLE 4 GLOBAL PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 86
  • TABLE 5 GLOBAL IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 87
  • TABLE 6 GLOBAL CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 88
  • TABLE 7 GLOBAL CONSUMABLES AND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 89
  • TABLE 8 GLOBAL KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 89
  • TABLE 9 GLOBAL REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 90
  • TABLE 10 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 94
  • TABLE 11 GLOBAL STOOL EXAMINATION IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 95
  • TABLE 12 GLOBAL BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 96
  • TABLE 13 GLOBAL BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 96
  • TABLE 14 GLOBAL IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 98
  • TABLE 15 GLOBAL IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 98
  • TABLE 16 GLOBAL TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 99
  • TABLE 17 GLOBAL TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 100
  • TABLE 18 GLOBAL BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 101
  • TABLE 19 GLOBAL OTHERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 101
  • TABLE 20 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 105
  • TABLE 21 GLOBAL STAGE III IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 106
  • TABLE 22 GLOBAL STAGE IV IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 107
  • TABLE 23 GLOBAL STAGE II IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 107
  • TABLE 24 GLOBAL STAGE I IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 108
  • TABLE 25 GLOBAL STAGE 0 IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 109
  • TABLE 26 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 113
  • TABLE 27 GLOBAL GERIATRIC IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 114
  • TABLE 28 GLOBAL ADULTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 115
  • TABLE 29 GLOBAL PEDIATRIC IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 116
  • TABLE 30 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 120
  • TABLE 31 GLOBAL ADENOCARCINOMA IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 121
  • TABLE 32 GLOBAL COLORECTAL LYMPHOMA IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 122
  • TABLE 33 GLOBAL GASTROINTESTINAL STROMAL TUMORS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 122
  • TABLE 34 GLOBAL CARCINOID TUMORS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 123
  • TABLE 35 GLOBAL OTHERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 124
  • TABLE 36 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 128
  • TABLE 37 GLOBAL HOSPITALS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 129
  • TABLE 38 GLOBAL DIAGNOSTIC CENTERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 130
  • TABLE 39 GLOBAL CANCER RESEARCH CENTERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 131
  • TABLE 40 GLOBAL AMBULATORY SURGICAL CENTERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 131
  • TABLE 41 GLOBAL ACADEMIC INSTITUTES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 132
  • TABLE 42 GLOBAL OTHERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 133
  • TABLE 43 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 139
  • TABLE 44 NORTH AMERICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 144
  • TABLE 45 NORTH AMERICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 144
  • TABLE 46 NORTH AMERICA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 144
  • TABLE 47 NORTH AMERICA PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 144
  • TABLE 48 NORTH AMERICA IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 145
  • TABLE 49 NORTH AMERICA CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 145
  • TABLE 50 NORTH AMERICA KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 145
  • TABLE 51 NORTH AMERICA REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 145
  • TABLE 52 NORTH AMERICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 146
  • TABLE 53 NORTH AMERICA BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 146
  • TABLE 54 NORTH AMERICA IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 146
  • TABLE 55 NORTH AMERICA TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 147
  • TABLE 56 NORTH AMERICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 147
  • TABLE 57 NORTH AMERICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 147
  • TABLE 58 NORTH AMERICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 148
  • TABLE 59 NORTH AMERICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 148
  • TABLE 60 U.S. COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 149
  • TABLE 61 U.S. INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 149
  • TABLE 62 U.S. PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 149
  • TABLE 63 U.S. IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 150
  • TABLE 64 U.S. CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 150
  • TABLE 65 U.S. KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 150
  • TABLE 66 U.S. REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 151
  • TABLE 67 U.S. COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 151
  • TABLE 68 U.S. BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 151
  • TABLE 69 U.S. IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 152
  • TABLE 70 U.S. TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 152
  • TABLE 71 U.S. COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 152
  • TABLE 72 U.S. COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 153
  • TABLE 73 U.S. COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 153
  • TABLE 74 U.S. COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 153
  • TABLE 75 CANADA COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 154
  • TABLE 76 CANADA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 154
  • TABLE 77 CANADA PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 154
  • TABLE 78 CANADA IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 155
  • TABLE 79 CANADA CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 155
  • TABLE 80 CANADA KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 155
  • TABLE 81 CANADA REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 156
  • TABLE 82 CANADA COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 156
  • TABLE 83 CANADA BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 156
  • TABLE 84 CANADA IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 157
  • TABLE 85 CANADA TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 157
  • TABLE 86 CANADA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 157
  • TABLE 87 CANADA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 158
  • TABLE 88 CANADA COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 158
  • TABLE 89 CANADA COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 158
  • TABLE 90 MEXICO COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 159
  • TABLE 91 MEXICO INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 159
  • TABLE 92 MEXICO PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 159
  • TABLE 93 MEXICO IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 160
  • TABLE 94 MEXICO CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 160
  • TABLE 95 MEXICO KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 160
  • TABLE 96 MEXICO REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 160
  • TABLE 97 MEXICO COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 161
  • TABLE 98 MEXICO BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 161
  • TABLE 99 MEXICO IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 161
  • TABLE 100 MEXICO TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 162
  • TABLE 101 MEXICO COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 162
  • TABLE 102 MEXICO COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 162
  • TABLE 103 MEXICO COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 163
  • TABLE 104 MEXICO COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 163
  • TABLE 105 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 168
  • TABLE 106 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 168
  • TABLE 107 EUROPE INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 168
  • TABLE 108 EUROPE PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 169
  • TABLE 109 EUROPE IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 169
  • TABLE 110 EUROPE CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 169
  • TABLE 111 EUROPE KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 170
  • TABLE 112 EUROPE REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 170
  • TABLE 113 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 170
  • TABLE 114 EUROPE BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 171
  • TABLE 115 EUROPE IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 171
  • TABLE 116 EUROPE TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 171
  • TABLE 117 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 172
  • TABLE 118 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 172
  • TABLE 119 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 172
  • TABLE 120 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 173
  • TABLE 121 GERMANY COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 174
  • TABLE 122 GERMANY INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 174
  • TABLE 123 GERMANY PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 174
  • TABLE 124 GERMANY IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 175
  • TABLE 125 GERMANY CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 175
  • TABLE 126 GERMANY KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 175
  • TABLE 127 GERMANY REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 175
  • TABLE 128 GERMANY COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 176
  • TABLE 129 GERMANY BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 176
  • TABLE 130 GERMANY IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 176
  • TABLE 131 GERMANY TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 177
  • TABLE 132 GERMANY COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 177
  • TABLE 133 GERMANY COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 177
  • TABLE 134 GERMANY COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 177
  • TABLE 135 GERMANY COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 178
  • TABLE 136 FRANCE COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 179
  • TABLE 137 FRANCE INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 179
  • TABLE 138 FRANCE PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 179
  • TABLE 139 FRANCE IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 180
  • TABLE 140 FRANCE CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 180
  • TABLE 141 FRANCE KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 180
  • TABLE 142 FRANCE REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 180
  • TABLE 143 FRANCE COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 181
  • TABLE 144 FRANCE BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 181
  • TABLE 145 FRANCE IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 181
  • TABLE 146 FRANCE TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 182
  • TABLE 147 FRANCE COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 182
  • TABLE 148 FRANCE COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 182
  • TABLE 149 FRANCE COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 183
  • TABLE 150 FRANCE COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 183
  • TABLE 151 U.K. COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 184
  • TABLE 152 U.K. INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 184
  • TABLE 153 U.K. PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 184
  • TABLE 154 U.K. IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 185
  • TABLE 155 U.K. CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 185
  • TABLE 156 U.K. KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 185
  • TABLE 157 U.K. REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 185
  • TABLE 158 U.K. COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 186
  • TABLE 159 U.K. BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 186
  • TABLE 160 U.K. IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 186
  • TABLE 161 U.K. TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 187
  • TABLE 162 U.K. COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 187
  • TABLE 163 U.K. COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 187
  • TABLE 164 U.K. COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 188
  • TABLE 165 U.K. COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 188
  • TABLE 166 ITALY COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 189
  • TABLE 167 ITALY INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 189

LIST OF FIGURES

  • FIGURE 1 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: SEGMENTATION 49
  • FIGURE 2 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: DATA TRIANGULATION 52
  • FIGURE 3 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: DROC ANALYSIS 53
  • FIGURE 4 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 54
  • FIGURE 5 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS 54
  • FIGURE 6 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS 56
  • FIGURE 7 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID 57
  • FIGURE 8 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: MARKET END USER COVERAGE GRID 58
  • FIGURE 9 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS 59
  • FIGURE 10 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: SEGMENTATION 63
  • FIGURE 11 THE INCREASE IN THE AWARENESS ABOUT COLORECTAL CANCER IS EXPECTED TO DRIVE THE GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET GROWTH IN THE FORECAST PERIOD 64
  • FIGURE 12 THE INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET IN 2023 & 2030 64
  • FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD 65
  • FIGURE 14 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET MANUFACTURERS IN THE FORECAST PERIOD 66
  • FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET 74
  • FIGURE 16 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2022 82
  • FIGURE 17 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION) 83
  • FIGURE 18 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 83
  • FIGURE 19 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, LIFELINE CURVE 84
  • FIGURE 20 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2022 92
  • FIGURE 21 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION) 93
  • FIGURE 22 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY TEST TYPE, CAGR (2023-2030) 93
  • FIGURE 23 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY TEST TYPE, LIFELINE CURVE 94
  • FIGURE 24 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, 2022 103
  • FIGURE 25 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, 2023-2030 (USD MILLION) 104
  • FIGURE 26 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, CAGR (2023-2030) 104
  • FIGURE 27 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, LIFELINE CURVE 105
  • FIGURE 28 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2022 111
  • FIGURE 29 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2023-2030 (USD MILLION) 112
  • FIGURE 30 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY AGE GROUP, CAGR (2023-2030) 112
  • FIGURE 31 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY AGE GROUP, LIFELINE CURVE 113
  • FIGURE 32 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2022 118
  • FIGURE 33 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2023-2030 (USD MILLION) 119
  • FIGURE 34 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, CAGR (2023-2030) 119
  • FIGURE 35 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, LIFELINE CURVE 120
  • FIGURE 36 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY END USER, 2022 126
  • FIGURE 37 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY END USER, 2023-2030 (USD MILLION) 127
  • FIGURE 38 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY END USER, CAGR (2023-2030) 127
  • FIGURE 39 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE 128
  • FIGURE 40 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 136
  • FIGURE 41 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY REGION (2022) 137
  • FIGURE 42 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY REGION (2023 & 2030) 137
  • FIGURE 43 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY REGION (2022 & 2030) 138
  • FIGURE 44 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE (2023-2030) 138
  • FIGURE 45 NORTH AMERICA COLORECTAL CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 141
  • FIGURE 46 NORTH AMERICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022) 142
  • FIGURE 47 NORTH AMERICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 142
  • FIGURE 48 NORTH AMERICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030) 143
  • FIGURE 49 NORTH AMERICA COLORECTAL CANCER DIAGNOSTICS MARKET: PRODUCT TYPE (2023-2030) 143
  • FIGURE 50 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 165
  • FIGURE 51 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022) 166
  • FIGURE 52 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 166
  • FIGURE 53 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030) 167
  • FIGURE 54 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: PRODUCT TYPE (2023-2030) 167
  • FIGURE 55 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 226
  • FIGURE 56 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022) 227
  • FIGURE 57 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 227
  • FIGURE 58 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030) 228
  • FIGURE 59 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: PRODUCT TYPE (2023-2030) 228
  • FIGURE 60 SOUTH AMERICA COLORECTAL CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 292
  • FIGURE 61 SOUTH AMERICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022) 293
  • FIGURE 62 SOUTH AMERICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 293
  • FIGURE 63 SOUTH AMERICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030) 294
  • FIGURE 64 SOUTH AMERICA COLORECTAL CANCER DIAGNOSTICS MARKET: PRODUCT TYPE (2023-2030) 294
  • FIGURE 65 MIDDLE EAST AND AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 312
  • FIGURE 66 MIDDLE EAST AND AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022) 313
  • FIGURE 67 MIDDLE EAST AND AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 313
  • FIGURE 68 MIDDLE EAST AND AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030) 314
  • FIGURE 69 MIDDLE EAST AND AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: PRODUCT TYPE (2023-2030) 314
  • FIGURE 70 GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%) 347
  • FIGURE 71 NORTH AMERICA COLORECTAL CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%) 348
  • FIGURE 72 EUROPE COLORECTAL CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%) 349
  • FIGURE 73 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%) 350
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!